Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 4/20 | 0.41 |
| ▸ | CA2 | P00918 | 4/20 | 0.41 |
| ▸ | CA12 | O43570 | 3/20 | 0.41 |
| ▸ | CA3 | P07451 | 3/20 | 0.41 |
| ▸ | CA4 | P22748 | 3/20 | 0.41 |
| ▸ | CA6 | P23280 | 3/20 | 0.41 |
| ▸ | CA5A | P35218 | 3/20 | 0.41 |
| ▸ | CA7 | P43166 | 3/20 | 0.41 |
| ▸ | CA9 | Q16790 | 3/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.41 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.41 |
| ▸ | CA13 | Q8N1Q1 | 2/20 | 0.41 |
| ▸ | CISD1 | Q9NZ45 | 1/20 | 0.41 |
| ▸ | CNR1 | P21554 | 1/20 | 0.40 |
| ▸ | GUSB | P08236 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | PGR | P06401 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29410051 | 1.00 | L3MBTL1 (0.44) | L3MBTL1CA1CA2CA12CA3 | |
| Hydrochloric Acid SCHEMBL27610010 | 0.97 | L3MBTL1 (0.42) | L3MBTL1CA1CA2CA12CA3 | |
| SCHEMBL13278133 | 0.97 | L3MBTL1 (0.42) | L3MBTL1CA1CA2CA12CA3 | |
| SCHEMBL1997081 | 0.97 | L3MBTL1 (0.42) | L3MBTL1CA1CA2CA12CA3 | |
| SCHEMBL13277972 | 0.97 | L3MBTL1 (0.42) | L3MBTL1CA1CA2CA12CA3 | |
| SCHEMBL13277223 | 0.97 | L3MBTL1 (0.42) | L3MBTL1CA1CA2CA12CA3 | |
| Potassium SCHEMBL29834163 | 0.97 | L3MBTL1 (0.42) | L3MBTL1CA1CA2CA12CA3 | |
| SCHEMBL13277813 | 0.97 | L3MBTL1 (0.42) | L3MBTL1CA1CA2CA12CA3 | |
| SCHEMBL2000643 | 0.97 | L3MBTL1 (0.42) | L3MBTL1CA1CA2CA12CA3 | |
| SCHEMBL10827572 | 0.95 | L3MBTL1 (0.41) | L3MBTL1CA1CA2CA12CA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 438 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114605310-B | Synthesis method of aza five-membered ring and three-membered ring carboxylic ester derivative and salt thereof | 都创(上海)医药科技股份有限公司 | 2024-05-07 | — | — | CN | claimed |
| CN-115232102-B | Preparation method and production device of lactide | 中国科学院长春应用化学研究所 | 2024-02-13 | — | — | CN | claimed |
| CN-117143443-A | Flame-retardant polycarbonate composition and preparation method and application thereof | 金发科技股份有限公司 | 2023-12-01 | — | — | CN | claimed |
| CN-113861651-B | Polycarbonate composition and preparation method and application thereof | 天津金发新材料有限公司 | 2023-05-09 | — | — | CN | claimed |
| CN-113149870-B | Synthetic method of 2,4,5-trichlorobenzene sulfonic acid | 武汉青江化工黄冈有限公司 | 2023-03-24 | — | — | CN | claimed |
| CN-115232102-A | Preparation method and production device of lactide | 中国科学院长春应用化学研究所 | 2022-10-25 | — | — | CN | claimed |
| CN-113861651-A | Polycarbonate composition and preparation method and application thereof | 天津金发新材料有限公司 | 2021-12-31 | — | — | CN | claimed |
| CN-113149870-A | Synthesis method of 2,4, 5-trichlorobenzene sulfonic acid | 武汉青江化工黄冈有限公司 | 2021-07-23 | — | — | CN | claimed |
| EP-3365168-B1 | LIGHTWEIGHT FLAME RETARDANT THERMOPLASTIC STRUCTURES | SCHNELLER LLC (US) | 2021-06-30 | — | — | EP | claimed |
| US-20210171437-A1 | PEPTIDE NUCLEIC ACID (PNA) MONOMERS WITH AN ORTHOGONALLY PROTECTED ESTER MOIETY AND NOVEL INTERMEDIATES AND METHODS RELATED THERETO | VERA THERAPEUTICS INC (US) | 2021-06-10 | — | — | US | claimed |
| EP-0615533-A1 | FLAME RESISTANT THERMOPLASTIC BLENDS HAVING REDUCED DRIPPAGE | GENERAL ELECTRIC COMPANY (US) | 1994-09-21 | — | — | EP | claimed |
| WO-1994007956-A1 | FLAME RESISTANT THERMOPLASTIC BLENDS HAVING REDUCED DRIPPAGE | GENERAL ELECTRIC COMPANY (US) | 1994-04-14 | — | — | WO | claimed |
| EP-0496396-A2 | 2,5-dichlorophenylthioglycolic acid derivative and method for its production | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 1992-07-29 | — | — | EP | claimed |
| US-5068405-A | Famotidine intermediates and their preparation | DELMAR CHEMICALS INC. (CA) | 1991-11-26 | — | — | US | claimed |
| CN-1042923-A | The preparation of polyketane polymers | SHELL INT RESEARCH (NL) | 1990-06-13 | — | — | CN | claimed |
| EP-0224292-B1 | PROCESS FOR THE PREPARATION OF ORGANIC ISOCYANATES | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1990-04-11 | — | — | EP | claimed |
| EP-0319083-A2 | Polyketone polymer preparation | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1989-06-07 | — | — | EP | claimed |
| EP-0224292-A1 | Process for the preparation of organic isocyanates | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1987-06-03 | — | — | EP | claimed |
| US-4670610-A | Preparation of 2,5-dichlorophenol | SANDOZ, INC. (CH) | 1987-06-02 | — | — | US | claimed |
| US-4171459-A | Manufacture of α-naphthol | BASF AKTIENGESELLSCHAFT (DE) | 1979-10-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210171437-A1 | PEPTIDE NUCLEIC ACID (PNA) MONOMERS WITH AN ORTHOGONALLY PROTECTED ESTER MOIETY AND NOVEL INTERMEDIATES AND METHODS RELATED THERETO | TARBP1, TIA1, SSB | L3MBTL1 983/4885CA1 145/4885CA2 976/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.